Abstract

BackgroundCheckpoint blockade therapies targeting programmed death ligand 1 (PD-L1) and its receptor programmed cell death 1 promote T cell-mediated immune surveillance against tumors and have been associated with significant clinical benefit in cancer patients. The long-stranded non-coding RNA HOTAIR is highly expressed and associated with metastasis in a variety of cancer types and promotes tumor metastasis at least in part through association with the PRC2 complex that induces redirection to hundreds of genes involved in tumor metastasis. Here, we report that HOTAIR is an activator lncRNA of the NF-κB pathway and demonstrate that its apparent upregulation promotes inflammatory signaling and immune escape in glioma cells.MethodsBioinformatics analysis was used to elucidate the relationship between HOTAIR and NF-κB pathway in HOTAIR knockdown glioma cells. At the cytological level, protein hybridization and immunofluorescence were used to detect the response of proteins in the NF-κB signaling pathway to HOTAIR regulation. ChIP and ChIRP experiments identified HOTAIR target genes. Animal experiments verified alterations in inflammation and immune escape following HOTAIR knockdown and activity inhibition.ResultsHOTAIR activated the expression of proteins involved in NF-κB, TNFα, MAPK and other inflammatory signaling pathways. In addition, HOTAIR induced various proteins containing protein kinase structural domains and promoted the enrichment of proteins and complexes of important inflammatory signaling pathways, such as the TNFα/NF-κB signaling protein complex, the IκB kinase complex, and the IKKA-IKKB complex. In addition, HOTAIR aberrantly activated biological processes involved in glioma immune responses, T-cell co-stimulation and transcription initiation by RNA polymerase II. HOTAIR facilitated the induction of IκBα phosphorylation by suppressing the expression of the NF-κB upstream protein UBXN1, promoting NF-κB phosphorylation and nuclear translocation. In vivo, reduction of HOTAIR decreased PD-L1 protein expression, indicating that cells are more likely to be targeted by immune T cells.ConclusionIn conclusion, our results provide convincing evidence that lncRNA HOTAIR drives aberrant gene transcription and immune escape from tumor cells through the NF-κB pathway.

Highlights

  • The role of the immune system in carcinogenesis remains unclear

  • An abnormally high expression of the lncRNA HOX antisense intergenic RNA (HOTAIR) has been previously demonstrated in glioma cells

  • We knocked down HOTAIR in glioma cells by siRNA with SILAC labeling, and total protein was extracted for proteome mass spectrometry

Read more

Summary

Introduction

The role of the immune system in carcinogenesis remains unclear. Checkpoints are negatively regulated pathways in the immune regulatory system and the malignant evolution of tumors effectively suppresses the immune response by activating the expression of checkpoints that enable them to actively evade detection. PD-1 is a cytokine receptor on the surface of T cells that is expressed on the surface of activated T cells and is capable of binding to two ligands, PD-L1 or PD-L2. Many cell types express PD-L1, including tumor cells and immune cells regulated by cytokines such as interferon (IFN)-g. Checkpoint blockade therapies targeting programmed death ligand 1 (PDL1) and its receptor programmed cell death 1 promote T cell-mediated immune surveillance against tumors and have been associated with significant clinical benefit in cancer patients. We report that HOTAIR is an activator lncRNA of the NF-kB pathway and demonstrate that its apparent upregulation promotes inflammatory signaling and immune escape in glioma cells

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call